n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Helicobacter Infections in 8 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walduck, AK | 1 |
| Weber, M | 1 |
| Wunder, C | 1 |
| Juettner, S | 1 |
| Stolte, M | 1 |
| Vieth, M | 1 |
| Wiedenmann, B | 1 |
| Meyer, TF | 1 |
| Naumann, M | 1 |
| Hoecker, M | 1 |
| Taira, K | 1 |
| Watanabe, T | 1 |
| Tanigawa, T | 1 |
| Shiba, M | 1 |
| Tominaga, K | 1 |
| Fujiwara, Y | 1 |
| Oshitani, N | 1 |
| Higuchi, K | 1 |
| Arakawa, T | 1 |
| Shah, AA | 1 |
| Byrne, MF | 1 |
| Cullen, L | 1 |
| Walsh, T | 1 |
| Fitzgerald, DJ | 1 |
| Murray, FE | 1 |
| Shirin, H | 1 |
| Moss, SF | 1 |
| Kancherla, S | 1 |
| Kancherla, K | 1 |
| Holt, PR | 1 |
| Weinstein, IB | 1 |
| Sordillo, EM | 1 |
| Takahashi, S | 2 |
| Fujita, T | 2 |
| Yamamoto, A | 2 |
| Kim, JM | 1 |
| Kim, JS | 1 |
| Jung, HC | 1 |
| Song, IS | 1 |
| Kim, CY | 1 |
| Kim, TI | 1 |
| Lee, YC | 1 |
| Lee, KH | 1 |
| Han, JH | 1 |
| Chon, CY | 1 |
| Moon, YM | 1 |
| Kang, JK | 1 |
| Park, IS | 1 |
8 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Helicobacter Infections
| Article | Year |
|---|---|
Identification of novel cyclooxygenase-2-dependent genes in Helicobacter pylori infection in vivo.
Topics: Animals; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Gastric Mucosa; Gene Expression Profiling; | 2009 |
Roles of cyclooxygenase-2 and prostaglandin E receptors in gastric mucosal defense in Helicobacter pylori-infected mice.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Ethanol; Female; Gastric Mucosa; Helicobacter Infection | 2007 |
Effect of H. pylori infection on the expression of cyclooxygenase-2 in human gastric mucosa.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Cyclooxygenase 2; Female; Gastric Mucosa; Helicobacter | 2003 |
Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, | 2006 |
Role of cyclooxygenase-2 in Helicobacter pylori- induced gastritis in Mongolian gerbils.
Topics: Animals; Chemokines; Chemotactic Factors; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2000 |
Nonsteroidal anti-inflammatory drug-induced acute gastric injury in Helicobacter pylori gastritis in Mongolian gerbils.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Dinoprostone; Gas | 2000 |
Upregulated cyclooxygenase-2 inhibits apoptosis of human gastric epithelial cells infected with Helicobacter pylori.
Topics: Apoptosis; Cell Line; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase | 2000 |
Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Division; Chronic Disease; Cycloox | 2001 |